CompletedPhase 1NCT02503839

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anne Margarita Dyrhol Riise
Principal Investigator
Anne Margarita Dyrhol-Riise, PhD
Oslo University Hospital
Intervention
etoricoxib(drug)
Enrollment
39 enrolled
Eligibility
18-70 years · All sexes
Timeline
2015 – 2020

Study locations (2)

Collaborators

University of Oslo · Statens Serum Institut · Haukeland University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02503839 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials